Ranbaxy gets USFDA nod to market `Panixine`
Ranbaxy Laboratories Ltd has announced that it has received approval from the US Food and Drug Administration (USFDA) to market its branded 'Panixine DisperDose' tablets (Cephalexin tablets for oral
Ranbaxy Laboratories Ltd has announced that it has received approval from the US Food and Drug Administration (USFDA) to market its branded 'Panixine DisperDose' tablets (Cephalexin tablets for oral